India, Nov. 1 -- Will the 30 per cent trade-margin cap materially improve cancer-care affordability, and what could limit its impact?

The NPPA's decision to cap trade margins at 30 per cent for 137 anti-cancer medicines is an important step towards improving medicine affordability. The measure has the potential to reduce the prices of the medicines covered, helping ease one component of the financial burden faced by patients and their families.

However, cancer care involves several interconnected costs, from screening and diagnosis to medicines, surgery, chemotherapy and radiation. The extent to which lower medicine prices translate into greater overall affordability will depend on how these different components come together across the...